Formation Elsevier SNDL :Soutenir le développement de la recherche scientifique – Partie I

Bibliothèque, Publication Scientifique, video


une formation de grande valeur et riche en contenu pour aider les chercheurs et les auteurs Algériens à ameliorer leur processus de recherche scientifique.

Présentateurs de webinaires:

  • M. Said Berrouk – Chef de Département de l’Information S&T – SNDL
  • Dr. Adel Belouchrani, Ph.D. – Electrical Engineering Department Ecole Nationale Polytechnique
  • Nadine Iskander – Conseillère de Recherche @ Elsevier
    https://m.youtube.com/watch?feature=share&v=cBdv_PJKCGo
Formation Elsevier DGRSDT SNDL SUR Webinar

Formation Elsevier DGRSDT SNDL SUR Webinar

archive, Publication Scientifique, Publication Scientifique Division Santé, Revue de Press

#Dgrsdt #Formation_Elsevier #Webinar #SNDL
#Prof_Hafid_Aourag #demain_le18Mai2020
📣📢🔴#Rendez vous au #webinar le 18 Mai 2020 à 12h00 (midi) heure locale de l’Algérie, pour une formation de grande valeur et riche en contenu pour aider les chercheurs et les auteurs Algériens à ameliorer leur processus de recherche scientifique
♦️Présentateurs de webinaires:
⭕#M_Hafid_Aourag : DG de La Recherche Scientifique – DGRSDT
⭕M. Said Berrouk: Chef de Département de l’Information S&T – SNDL
⭕Mme  Nadine Iskander : Conseillère de Recherche @ Elsevier
✅#Accedez_au_webinar: https://elsevier.zoom.us/j/91129104704?pwd=YVM4TkN3TFVLL3R6YmtiMXJtQ1hyQT09
#Inscrivez_vous: https://researcheracademy.elsevier.com/workshop/737c6559-3556-4595-a8ef-37ed8a538111

recently published article in the prestigious German press DW recognising our scientific contribution on the potential repurposing of artemisinin against SARS-CoV-2.

recently published article in the prestigious German press DW recognising our scientific contribution on the potential repurposing of artemisinin against SARS-CoV-2.

archive, Publication Scientifique, Publication Scientifique Division Santé, Revue de Press, URADTE

A recently published article in the prestigious German press DW recognising our scientific contribution on the potential repurposing of artemisinin against SARS-CoV-2. The article also recognised the current efforts of other scientists from the Max Planck Institute in Potsdam, Germany, namely the research group of Prof. Peter Seeberger, in collaboration with investigators from Denmark in performing preclinical studies of this active ingredient against the virus. Very well done to everyone contributing to the success of this project, especially my colleague Dr. Smain Chemat. #crapc #artemisinin #sweetwormwood #sars_cov_2 #drug_repurposing
https://amp-dw-com.cdn.ampproject.org/c/s/amp.dw.com/de/angebliches-covid-19-wundermittel-artemisia-im-testlabor/a-53428761

New Article [MOLSTR_128325] published in Journal of Molecular Structure

New Article [MOLSTR_128325] published in Journal of Molecular Structure

archive, Bibliothèque, Publication Scientifique, Publication Scientifique Division Santé, Revue de Press

Multicomponent and 1,3-dipolar cycloaddition synthesis of triazole- and isoxazole-acridinedione/xanthenedione heterocyclic hybrids: Cytotoxic effects on human cancer cells

https://www.sciencedirect.com/science/article/pii/S0022286020306505?dgcid=author

Author links open overlay panelAbdelkaderNaouriabcAmarDjemouiabMouhamad RidhaOuahranidMokhtar BoualemLahrechbNajetLemouaricDjenisa H.A.RochaefgHélioAlbuquerqueeRicardo F.MendesfFilipe A.Almeida PazfLuisa A.HelguerogKhaldounBacharicOualidTalhiceArtur M.S.Silvae

Abstract

A new series of diverse 1,2,3-triazole-acridinedione/xanthenedione and 1,2-isoxazole-acridinedione/xanthenedione heterocyclic hybrids have been synthesized via 1,3-dipolar coupling reaction of N/O-substituted-acridinedione-alkyne or O-substituted-xanthenedione-alkyne substrates with various aromatic azides or oximes. In all cases, the cycloaddition is totally regioselective. The chemical structures of the synthesized compounds are determined using 2D NMR and are further confirmed by single-crystal X-ray diffraction analysis. Preliminary in vitro cytotoxic assays on two human breast cancer cell lines (MDA-MB-231, T47-D) and one prostate cancer cell line (PC3) are performed on some selected compounds. The most active O-1,2,3-triazole-xanthenedione hybrid displays the best cytotoxicity effects with IC50 ≤ 20 μM in breast cancer and IC50 = 10 μM in prostate cancer cell lines.